PAPPA2 is increased in severe early onset pre-eclampsia and upregulated with hypoxia

Reproduction, Fertility and Development

Volumn 26, Issue 2, 2014, Pages 351-357

  Macintire, Kate ^a   Tuohey, Laura ^a   Ye, Louie ^a   Palmer, Kirsten ^a   Gantier, Michael ^b   Tong, Stephen ^a   Kaitu'u Lino, Tu'uhevaha J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Placenta; Pregnancy

Indexed keywords

MESSENGER RNA; PREGNANCY ASSOCIATED PROTEIN; PREGNANCY ASSOCIATED PROTEIN A2; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; COMPUTER MODEL; CONTROLLED STUDY; EXPLANT; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; PLACENTA; PREECLAMPSIA; PROMOTER REGION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNCYTIOTROPHOBLAST; UPREGULATION; WESTERN BLOTTING;

CASE-CONTROL STUDIES; CELL HYPOXIA; CELL LINE; FEMALE; GESTATIONAL AGE; HUMANS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TISSUE CULTURE TECHNIQUES; TROPHOBLASTS; UP-REGULATION; VICTORIA;

EID: 84891799922     PISSN: 10313613     EISSN: 14485990     Source Type: Journal    
DOI: 10.1071/RD12384     Document Type: Article

References (24)

1. American Congress of Obstetricians and Gynecologists (ACOG) (2002). Diagnosis and management of pre-eclampsia and eclampsia. ACOG Practice Bulletin No. 33. Obstet. Gynecol. 99, 159-167. doi:10.1016/S0029-7844(01)01747-1
2. Aye, I. L., Waddell, B. J., Mark, P. J., and Keelan, J. A. (2011). Oxysterols inhibit differentiation and fusion of term primary trophoblasts by activating liver X receptors. Placenta 32, 183-191. doi:10.1016/J.PLACENTA.2010. 12.007
3. Buimer, M., Keijser, R., Jebbink, J. M., Wehkamp, D., van Kampen, A. H., Boer, K., van der Post, J. A., and Ris-Stalpers, C. (2008). Seven placental transcripts characterize HELLP-syndrome. Placenta 29, 444-453. doi:10.1016/J.PLACENTA.2008.02.007
4. Conover, C. A., Boldt, H. B., Bale, L. K., Clifton, K. B., Grell, J. A., Mader, J. R., Mason, E. J., and Powell, D. R. (2011). Pregnancyassociated plasma protein-A2 (PAPP-A2): tissue expression and biological consequences of gene knockout in mice. Endocrinology 152, 2837-2844. doi:10.1210/EN.2011-0036
5. Culver, C., Sundqvist, A., Mudie, S., Melvin, A., Xirodimas, D., and Rocha, S. (2010). Mechanism of hypoxia-induced NF-kappaB. Mol. Cell. Biol. 30, 4901-4921. doi:10.1128/MCB.00409-10
6. Grill, S., Rusterholz, C., Zanetti-Dallenbach, R., Tercanli, S., Holzgreve, W., Hahn, S., and Lapaire, O. (2009). Potential markers of preeclampsia: a review. Reprod. Biol. Endocrinol. 7, 70. doi:10.1186/1477-7827- 7-70
7. Levine, R. J., Maynard, S. E., Qian, C., Lim, K.-H., England, L. J., Yu, K. F., Schisterman, E. F., Thadhani, R., Sachs, B. P., Epstein, F. H., Sibai, B. M., Sukhatme, V. P., and Karumanchi, S. A. (2004). Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 350, 672-683. doi:10.1056/NEJMOA031884 (Pubitemid 38364626)
8. Messeguer, X., Escudero, R., Farre, D., Nunez, O., Martinez, J., and Alba, M. M. (2002). PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics 18, 333-334. doi:10.1093/BIOINFORMATICS/18.2.333 (Pubitemid 34183117)
9. Moffett-King, A. (2002). Natural killer cells and pregnancy. Nat. Rev. Immunol. 2, 656-663. doi:10.1038/NRI886 (Pubitemid 37328723)
10. Nishizawa, H., Pryor-Koishi, K., Suzuki, M., Kato, T., Kogo, H., Sekiya, T., Kurahashi, H., and Udagawa, Y. (2008). Increased levels of pregnancyassociated plasma protein-A2 in the serum of pre-eclamptic patients. Mol. Hum. Reprod. 14, 595-602. doi:10.1093/MOLEHR/GAN054
11. Paiva, P., Whitehead, C., Saglam, B., Palmer, K., and Tong, S. (2011). Measurement of mRNA transcripts of very high placental expression in maternal blood as biomarkers of preeclampsia. J. Clin. Endocrinol. Metab. 96, E1807-E1815. doi:10.1210/JC.2011-1233
12. Powe, C. E., Levine, R. J., and Karumanchi, S. A. (2011). Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 123, 2856-2869. doi:10.1161/CIRCULATIONAHA.109.853127
13. Redman, C. W., and Sargent, I. L. (2005). Latest advances in understanding preeclampsia. Science 308, 1592-1594. doi:10.1126/SCIENCE.1111726 (Pubitemid 40807500)
14. Rius, J., Guma, M., Schachtrup, C., Akassoglou, K., Zinkernagel, A. S., Nizet, V., Johnson, R. S., Haddad, G. G., and Karin, M. (2008). NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453, 807-811. doi:10.1038/NATURE06905 (Pubitemid 351793778)
15. Sibai, B., Dekker, G., and Kupferminc, M. (2005). Pre-eclampsia. Lancet 365, 785-799 (Pubitemid 40311367)
16. Sitras, V., Paulssen, R. H., Gronaas, H., Leirvik, J., Hanssen, T. A., Vartun A., and Acharya, G. (2009). Differential placental gene expression in severe preeclampsia. Placenta 30, 424-433. doi:10.1016/J.PLACENTA.2009.01.012
17. Valbuena-Diez, A. C., Blanco, F. J., Oujo, B., Langa, C., Gonzalez-Nunez, M., Llano, E., Pendas, A. M., Diaz, M., Castrillo, A., Lopez-Novoa, J.M., and Bernabeu, C. (2012). Oxysterol-induced soluble endoglin release and its involvement in hypertension. Circulation 126, 2612-2624. doi:10.1161/ CIRCULATIONAHA.112.101261
18. Várkonyi, T., Nagy, B., Fule, T., Tarca, A. L., Karaszi, K., Schonleber, J., Hupuczi, P., Mihalik, N., Kovalszky, I., Rigo, J. Jr, Meiri, H., Papp, Z., Romero, R., and Than, N. G. (2011). Microarray profiling reveals that placental transcriptomes of early-onset HELLP syndrome and preeclampsia are similar. Placenta 32(Suppl.), S21-S29. doi:10.1016/J.PLACENTA.2010.04.014
19. Venkatesha, S., Toporsian, M., Lam, C., Hanai, J., Mammoto, T., Kim, Y. M., Bdolah, Y., Lim, K. H., Yuan, H. T., Libermann, T. A., Stillman, I. E., Roberts, D., D'Amore, P. A., Epstein, F. H., Sellke, F. W., Romero, R., Sukhatme, V. P., Letarte, M., and Karumanchi, S. A. (2006). Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat. Med. 12, 642-649. doi:10.1038/NM1429 (Pubitemid 43865232)
20. Wagner, P. K., and Christians, J. K. (2010). Altered placental expression of PAPPA2 does not affect birth weight in mice. Reprod. Biol. Endocrinol. 8, 90. doi:10.1186/1477-7827-8-90
21. Wagner, P. K., Otomo, A., and Christians, J. K. (2011). Regulation of pregnancy-associated plasma protein A2 (PAPPA2) in a human placental trophoblast cell line (BeWo). Reprod. Biol. Endocrinol. 9, 48. doi:10.1186/1477-7827-9-48
22. Wang, J., Qiu, Q., Haider, M., Bell, M., Gruslin, A., and Christians, J. K. (2009). Expression of pregnancy-associated plasma protein A2 during pregnancy in human and mouse. J. Endocrinol. 202, 337-345. doi:10.1677/JOE-09-0136
23. Winn, V. D., Gormley, M., Paquet, A. C., Kjaer-Sorensen, K., Kramer, A., Rumer, K. K., Haimov-Kochman, R., Yeh, R. F., Overgaard, M. T., Varki, A., Oxvig, C., and Fisher, S. J. (2009). Severe preeclampsiarelated changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2. Endocrinology 150, 452-462. doi:10.1210/EN.2008-0990
24. Zhong, H., and Simons, J. W. (1999). Direct comparison of GAPDH, betaactin, cyclophilin, and 28S rRNA as internal standards for quantifying RNA levels under hypoxia. Biochem. Biophys. Res. Commun. 259, 523-526. doi:10.1006/BBRC.1999.0815 (Pubitemid 29335566)